| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740350 | Journal of Infection | 2018 | 25 Pages |
Abstract
PHN risk was higher in women and increased with age and comorbidities. At least 32% and 7% of people will develop HZ and PHN, respectively, between ages 50-90 years. These results should be considered for vaccine policy implementation.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Cintia Muñoz-Quiles, Mónica López-Lacort, Alejandro Orrico-Sánchez, Javier DÃez-Domingo,